Explore 3 Stock Ideas & Industry Insights Download Free Report

JD Health International Inc

Company price
5.275 USD 0.00(0%)
Last update at 2026-11-05T21:00:00Z
VOLUME
1000
Market Cap
15943.10M
P/E
62.50

Momentum Score

…

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. In addition, it is involved in order management, client management, and other merchants operational and maintenance support activities. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. operates as a subsidiary of JD Jiankang Limited.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.65
Low
5.28
High
52 Week Price Range
5.00
Low
9.88
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

JD Health International Inc provides online healthcare and pharmacy services in China, including telemedicine, prescription fulfillment and health-management offerings via a digital platform linked to JD.com's e-commerce and logistics network. Long-term growth may be supported by China's aging population, rising digital-health adoption and the shift of pharmacy and chronic-care services online, with scale and platform integration appearing to support market penetration.

Key risks are regulatory and policy shifts in China's healthcare and internet sectors, intense competition from other tech-backed healthcare providers, and execution and profitability pressure as the company expands.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
5.28
Dividend Yield
-
Revenue TTM
53621.27M
Revenue Per Share
17.22
Gross Profit TTM
7197.28M
Debt / Equity
0.00
ROE
3.78%
Net Debt
-18518.31M
ROCE
1.79%
Diluted EPS TTM
0.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 695.81M -901.49M -17072.14M -834.70M 306.23M
Minority interest -3.12M -0.69M 0.53M 0.00M 0.00M
Net income 380.11M -1073.51M -17234.36M -971.80M 214.93M
Selling general administrative 2153.53M 5536.22M 2521.93M 1247.63M 1029.13M
Selling and marketing expenses 2195.76M 2133.84M 1434.59M 746.01M 391.82M
Gross profit 9891.51M 7197.28M 4917.30M 2812.27M 1978.96M
Reconciled depreciation 140.68M 63.17M 27.22M 7.42M 6.27M
Ebit 803.11M -857.14M -17068.61M -797.34M 310.77M
Ebitda 943.79M -793.97M -17041.39M -789.92M 317.03M
Depreciation and amortization 140.68M 63.17M 27.22M 7.42M 6.27M
Operating income 803.11M -857.14M -17068.61M -797.34M 310.77M
Other operating expenses 46783.07M 32047.96M 19030.85M 10408.70M 7861.94M
Interest expense 9.10M 6.00M 3.42M 35.50M 0.15M
Tax provision 312.58M 171.33M 162.76M 137.10M 91.31M
Interest income 864.27M 457.57M 149.12M 31.78M 0.08M
Net interest income 855.17M 451.57M 145.70M -3.72M -0.07M
Income tax expense 312.58M 171.33M 162.76M 137.10M 91.31M
Total revenue 46736.15M 30682.27M 19382.57M 10842.14M 8169.06M
Total operating expenses 9938.43M 8562.98M 4565.58M 2378.83M 1671.84M
Cost of revenue 36844.64M 23484.99M 14465.27M 8029.87M 6190.10M
Total other income expense net -107.30M -44.35M -3.53M -37.36M -4.54M
Net income from continuing ops 383.23M -1072.82M -17234.90M -971.80M 214.93M
Net income applicable to common shares - -1073.51M -17234.36M -971.80M 214.93M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 61277.30M 48002.22M 43994.55M 8676.68M 1182.15M
Other current assets 757.41M 8.61M 4.52M 2.50M 3.02M
Total liab 16492.73M 8147.63M 4743.20M 9135.71M 432.93M
Total stockholder equity 44780.25M 39853.39M 39250.84M -459.03M 749.22M
Other current liab 5759.48M 2452.41M 1753.63M 1095.04M 89.57M
Common stock 0.01M 0.01M 0.01M 0.01M 2.00M
Capital stock 0.01M 0.01M 0.01M 0.01M 2.00M
Retained earnings -19382.06M -19714.84M -18616.76M -1368.79M -94.77M
Other liab - 8.89M - - -
Other assets 787.45M 979.65M 432.13M 28.39M 1.27M
Cash 18717.72M 17252.29M 32270.79M 4965.27M 16.21M
Total current liabilities 16356.15M 8005.03M 4681.79M 1544.88M 430.51M
Net debt -18518.31M -17051.03M -32180.81M -4954.01M -13.09M
Short term debt 70.65M 67.55M 28.57M 4.85M 0.71M
Short long term debt total 199.41M 201.27M 89.98M 11.26M 3.13M
Other stockholder equity 64162.30M 59568.22M 57867.59M 909.75M 841.99M
Property plant equipment - 260.77M 115.01M 16.20M 4.37M
Total current assets 56447.16M 45705.48M 42704.77M 8624.04M 1166.34M
Net tangible assets - 39828.00M 39222.35M -459.63M 746.46M
Short term investments 28248.49M 24737.78M 8032.61M 1395.24M -
Net receivables 2727.27M 665.54M 664.46M 982.70M 31.80M
Inventory 5996.27M 3041.24M 1732.39M 1278.34M 1115.30M
Accounts payable 10526.03M 5485.07M 2899.60M 444.98M 340.23M
Non currrent assets other 28727.07M 25473.60M 8282.98M 1422.43M 7.73M
Non current assets total 4830.14M 2296.74M 1289.78M 52.63M 15.81M
Capital lease obligations 199.41M 201.27M 89.98M 11.26M 3.13M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -4235.54M -17247.24M -7558.57M -1440.91M -7.41M
Change to liabilities 6020.50M 2801.42M 2539.91M 151.92M 176.87M
Total cashflows from investing activities - -17752.15M -7842.58M -1448.62M -13.69M
Net borrowings -47.56M -32.33M -242.92M 200.70M -2.77M
Total cash from financing activities -925.45M -163.65M 32028.69M 6509.12M -2.92M
Change to operating activities 665.08M 843.36M 945.75M 43.12M 4.03M
Net income 383.23M -1072.82M -17234.90M -971.80M 214.93M
Change in cash 1465.43M -15018.50M 27305.52M 4949.06M 8.81M
Begin period cash flow 17252.29M 32270.79M 4965.27M 16.21M 7.40M
End period cash flow 18717.72M 17252.29M 32270.79M 4965.27M 16.21M
Total cash from operating activities 5905.15M 3430.72M 3699.46M 409.47M 187.23M
Issuance of capital stock - 0.00M 32274.05M 6310.66M 0.00M
Depreciation 140.68M 63.17M 27.22M 7.42M 6.27M
Other cashflows from investing activities -5.41M 5.18M -242.91M -2.03M -3.86M
Change to inventory -3151.38M -1286.16M -522.21M -164.03M -232.37M
Change to account receivables -685.08M -331.40M -47.66M -3.38M -21.33M
Sale purchase of stock -869.03M -126.41M - - -
Other cashflows from financing activities -56.41M -37.25M 6242.70M 6509.11M -2.92M
Change to netincome 2535.23M 2413.84M 17990.80M 1346.21M 38.83M
Capital expenditures 2272.95M 518.16M 38.79M 5.69M 2.42M
Change in working capital 2849.14M 2027.21M 2915.80M 27.64M -72.80M
Stock based compensation 2104.28M 2579.71M 380.30M 52.73M 33.47M
Other non cash items 427.83M -166.55M 17611.04M 1293.48M 5.36M
Free cash flow 3632.20M 2912.56M 3660.68M 403.78M 184.81M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
JDHIY
JD Health International Inc
-
-%
5.28 62.50 35.97 0.30 2.32 0.16 3.90
HCA
HCA Healthcare, Inc.
-12.31
2.43%
495.17 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
-2.95
1.03%
283.51 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
0.02
0.14%
14.44 16.87 9.44 0.42 0.78 0.79 5.37
FMCQF
Fresenius Medical Care AG & Co. KGaA
-
-%
47.84 14.21 9.00 0.78 0.77 0.98 5.67

Profile*

JD Health International Inc

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. In addition, it is involved in order management, client management, and other merchants operational and maintenance support activities. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. operates as a subsidiary of JD Jiankang Limited.

Jingdong Headquarters, Beijing, China, 101111

2751

Name Title Year Born
Mr. Enlin Jin CEO & Exec. Director 1981
Mr. Dong Cao Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…